CBLLCeriBell, Inc.
Price
+96%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, a flag to check, growth steady, the market with it.
Charts
As reported to the SEC, without any scoring.
CeriBell, Inc. (CBLL) reported revenue of $28M in Q2 2026 (quarter ended Jun 30, 2026), up 33% from the same quarter a year earlier. That came with a gross margin of 92% and net loss of $19M. For the full year FY2025, revenue was $89M (+36% year on year) and net income −$53M. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 10, 2026Ceribell Reports Second Quarter 2026 Financial Results.Earnings release · press release
- Jul 30, 2026Effective July 28, 2026, the Board of Directors (the “Board”) of CeriBell, Inc. (the “Company”), in order to achieve a more balanced membership among the classes of directors, accepted the resignation of William W. Burke as a Class I director and immediately elected him as a Class II director, and accepted the …Director or officer change · Form 8-K
- May 11, 2026Ceribell Reports First Quarter 2026 Financial Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Devices
The closest names by size in the same industry